Obstetrics and Gynecology Department, LiShui City People's Hospital, No. 1188, Liyang Street, Lishui City, 323000, Zhejiang Province, China.
Arch Gynecol Obstet. 2024 Jan;309(1):259-268. doi: 10.1007/s00404-023-07173-8. Epub 2023 Aug 4.
This meta-analysis aimed to evaluate the effects of hysteroscopic surgery combined with progesterone therapy on fertility and prognosis in patients with early endometrial cancer (EC), atypical endometrial hyperplasia (AEH), or endometrial intraepithelial neoplasia (EIN).
Studies on hysteroscopic surgery combined with progesterone therapy for patients with early-stage EC, AEH, or EIN were searched from Embase, Web of Science, PubMed, and Cochrane Library databases. The included studies contained one or more of the following outcome variables: pregnancy rate, live birth rate, complete response (CR) rate, and recurrence rate after conservative treatment. The meta-analysis was performed using Stata.
13 pieces of literature containing 239 patients with EC and 199 patients with AEH/EIN were included. As per the results of meta-analysis, the pregnancy rates of EC patients and AEH/EIN patients were 49% (95% CI 33-65%) and 47% (95% CI 31-64%), respectively, and the live birth rates were 45% (95% CI 32-58%) and 44% (95% CI 34-54%), respectively. CR rates of EC patients and AEH/EIN patients were 90% (95% CI 85-94%) and 100% (95% CI 97-100%), respectively, and the disease recurrence rates were 17% (95% CI 8-28%) and 11% (95% CI 3-23%), respectively.
Hysteroscopic surgery combined with progesterone was linked to an improved overall response rate, reduced disease recurrence rate, and increased pregnancy and live birth rates among patients with EC and AEH/EIN.
本荟萃分析旨在评估宫腔镜手术联合孕激素治疗对早期子宫内膜癌(EC)、非典型子宫内膜增生(AEH)或子宫内膜上皮内瘤变(EIN)患者生育和预后的影响。
从 Embase、Web of Science、PubMed 和 Cochrane Library 数据库中搜索关于宫腔镜手术联合孕激素治疗早期 EC、AEH 或 EIN 患者的研究。纳入的研究包含以下一个或多个结局变量:妊娠率、活产率、完全缓解(CR)率和保守治疗后复发率。使用 Stata 进行荟萃分析。
纳入了 13 篇文献,其中包含 239 例 EC 患者和 199 例 AEH/EIN 患者。荟萃分析结果显示,EC 患者和 AEH/EIN 患者的妊娠率分别为 49%(95%CI 33-65%)和 47%(95%CI 31-64%),活产率分别为 45%(95%CI 32-58%)和 44%(95%CI 34-54%)。EC 患者和 AEH/EIN 患者的 CR 率分别为 90%(95%CI 85-94%)和 100%(95%CI 97-100%),疾病复发率分别为 17%(95%CI 8-28%)和 11%(95%CI 3-23%)。
宫腔镜手术联合孕激素治疗可提高 EC 和 AEH/EIN 患者的总体缓解率,降低疾病复发率,增加妊娠和活产率。